296
Participants
Start Date
March 12, 2018
Primary Completion Date
March 21, 2019
Study Completion Date
August 7, 2019
SAR440340
Pharmaceutical form: Solution for Injection, Route of administration: SC
Dupilumab
Pharmaceutical form: Solution for Injection, Route of administration: SC
Fluticasone or Fluticasone/salmeterol combination
Pharmaceutical form: Aerosol, dry powder, Route of administration: Inhaled
Placebo for SAR440340
Pharmaceutical form: Solution for Injection, Route of administration: SC
Placebo for dupilumab
Pharmaceutical form: Solution for Injection, Route of administration: SC
Investigational Site Number 0320005, Mendoza
Investigational Site Number 7920003, Bursa
Investigational Site Number 8040005, Vinnytsia
Investigational Site Number 8400007, Papillion
Investigational Site Number 4840005, Chihuahua City
Investigational Site Number 7920002, Mersin
Investigational Site Number 4840004, Durango
Investigational Site Number 7920001, Istanbul
Investigational Site Number 7920006, Izmir
Investigational Site Number 7920007, Izmir
Investigational Site Number 8400026, Birmingham
Investigational Site Number 4840002, Guadalajara
Investigational Site Number 8040003, Ternopil
Investigational Site Number 8400021, Ann Arbor
Investigational Site Number 7920009, Rize
Investigational Site Number 8400014, Milwaukee
Investigational Site Number 8400022, Minneapolis
Investigational Site Number 8040008, Chernivtsi
Investigational Site Number 8040002, Kharkiv
Investigational Site Number 8040009, Kharkiv
Investigational Site Number 8040011, Kharkiv
Investigational Site Number 4840006, Monterrey
Investigational Site Number 8040006, Odesa
Investigational Site Number 4840001, Monterrey
Investigational Site Number 7920008, Kırıkkale
Investigational Site Number 8400025, Edmond
Investigational Site Number 8400006, Plano
Investigational Site Number 8400010, Dallas
Investigational Site Number 8400023, Dallas
Investigational Site Number 8040012, Ivano-Frankivsk
Investigational Site Number 8400016, Colorado Springs
Investigational Site Number 8400008, Murray
Investigational Site Number 8400020, Los Angeles
Investigational Site Number 8400001, Rolling Hills Estates
Investigational Site Number 8400004, Long Beach
Investigational Site Number 4840003, Veracruz
Investigational Site Number 8400013, San Jose
Investigational Site Number 8400009, Stockton
Investigational Site Number 8400024, Portland
Investigational Site Number 8400011, Medford
Investigational Site Number 6430003, Moscow
Investigational Site Number 6430001, Moscow
Investigational Site Number 6430005, Moscow
Investigational Site Number 6430007, Saint Petersburg
Investigational Site Number 6430010, Saint Petersburg
Investigational Site Number 6430006, Saint Petersburg
Investigational Site Number 6430009, Stavropol
Investigational Site Number 6430008, Ryazan
Investigational Site Number 6430004, Ulyanovsk
Investigational Site Number 1520002, Quillota
Investigational Site Number 1520001, Santiago
Investigational Site Number 1520009, Santiago
Investigational Site Number 1520008, Santiago
Investigational Site Number 1520007, Santiago
Investigational Site Number 1520004, Santiago
Investigational Site Number 0320001, Buenos Aires
Investigational Site Number 0320003, Caba
Investigational Site Number 0320002, Caba
Investigational Site Number 0320004, Caba
Investigational Site Number 1520005, Talca
Investigational Site Number 1520003, Viña del Mar
Investigational Site Number 6160001, Bialystok
Investigational Site Number 6160008, Bialystok
Investigational Site Number 6160005, Bydgoszcz
Investigational Site Number 6160007, Krakow
Investigational Site Number 6160002, Poznan
Investigational Site Number 6160006, Poznan
Investigational Site Number 6160003, Żnin
Investigational Site Number 7920004, Ankara
Investigational Site Number 8040007, Kyiv
Investigational Site Number 8040001, Kyiv
Lead Sponsor
Regeneron Pharmaceuticals
INDUSTRY
Sanofi
INDUSTRY